Novartis, the global leader in GIST therapy, has been working with healthcare professionals and patients worldwide to help improve the treatment of GIST (gastrointestinal stromal tumors).
Novartis introduces GIST Alliance™, a unique support program designed to help healthcare professionals optimize outcomes in GIST patients.
GIST Alliance: Find a Glivec Blood Level Testing Lab for Your Patients
References:
1.
Demetri GD, Wang Y, Wehrle E, Blanke C, Joensuu H, von Mehren M. Correlation of imatinib plasma levels with clinical benefit in patients (Pts) with unresectable/metastatic gastrointestinal stromal tumors (GIST). Presented at: ASCO Gastrointestinal Cancers Symposium; January 25-27, 2008; Orlando, FL. Abstract 3 and Slides.
2.
von Mehren M, Wang Y, Joensuu H, Blanke CD, Wehrle E, Demetri GD. Imatinib pharmacokinetics (PK) and its correlation with clinical response in patients with unresectable/metastatic gastrointestinal stromal tumor (GIST). J Clin Oncol. 2008;26(suppl):Abstract 4523.